Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 500 results in range #1,001 to #1,500.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. GISSI-2Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardico Acuto-2
  2. GISSI-HF: n-3 PUFAGruppo Italiano Per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico–Heart Failure: N-3 Pufa
  3. GISSI-HF: RosuvastatinGruppo Italiano Per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico–Heart Failure: Rosuvastatin
  4. Guidewore PT graphix intermediateGuidewire PT graphix intermediate
  5. PT Graphix intermediate wireGuidewire PT graphix intermediate
  6. Stabilizer wireGuidewire stabilizer
  7. Commonly used guidewiresGuidewires commonly used
  8. Guillaume François RouelleGuillaume-François Rouelle
  9. DupuytrenGuillaume Dupuytren
  10. Guinea Worm DiseaseGuinea worm Disease
  11. Robert HorvitzH. Robert Horvitz
  12. H5N1 genesH5N1 genetic structure
  13. Hepatitis B with HIV coninfectionHIV coninfection with hepatitis b
  14. Nef gene productHIV structure and genome#Nef
  15. Structure and genome of HIVHIV structure and genome
  16. HYPERSENSITIVITY REACTIONSHYPERSENSITIVITY
  17. Habitual aborterHabitual abortion
  18. Recurrent pregnancy lossHabitual abortion
  19. EpilationHair removal
  20. DepilatoryHair removal
  21. Sin Nombre virus infectionHantavirus pulmonary syndrome
  22. Sin nombre virus infectionHantavirus pulmonary syndrome
  23. Harm minimizationHarm reduction
  24. HORIZONS-AMI StentHarmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction
  25. HORIZONS-AMIHarmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction
  26. HARPHarvard Atherosclerosis Reversibility Project
  27. HACCPHazard Analysis and Critical Control Points
  28. NitsHead Lice Infestation
  29. Headache in kidsHeadache in children
  30. HANDLSHealth Aging In Nationally Diverse Longitudinal Samples
  31. HORIZONHealth Outcomes And Reduced Incidence With Zoledronic Once Yearly
  32. Health claimHealth claims on food labels
  33. Health PhysicsHealth physics
  34. Radiation Health PhysicsHealth physics
  35. Balanced dietHealthy diet
  36. HDOMHeart Disease On The Mend
  37. HF-ACTIONHeart Failure–A Randomized Controlled Trial Investigating Outcomes Of Exercise Training
  38. HIJ-CREATEHeart Institute Of Japan Candesartan Randomized Trial For Evaluation In Coronary Artery Disease
  39. HOPE-2Heart Outcomes Prevention Evaluation
  40. HOPE-TOOHeart Outcomes Prevention Evaluation - The Ongoing Outcomes
  41. Heavy chainsHeavy chain
  42. HeidelbergHeidelberg Trial
  43. HAAMU-STENTHelsinki Area Acute Myocardial Infarction Treatment Re-Evaluation - Should The Patients Get A Drug-Eluting Or Normal Stent
  44. Hemangioendothelioma chest x rayHemangioendothelioma x ray
  45. HeADDFIRSTHemicraniectomy And Durotomy For Deterioration From Infarction Relating Swelling Trial
  46. Haemophilia AHemophilia A
  47. Factor VIII deficiencyHemophilia A
  48. Hæmophilia AHemophilia A
  49. Haemophilia type AHemophilia A
  50. Haemophilia BHemophilia B
  51. Christmas diseaseHemophilia B
  52. Hæmophilia BHemophilia B
  53. Factor IX DeficiencyHemophilia B
  54. HEMEHemorrhage Early Mri Evaluation
  55. Claude syndromeHenri Claude
  56. Carl Peter Henrik DamHenrik Dam
  57. Clutton's jointsHenry Hugh Clutton
  58. HARTHeparin-Aspirin Reperfusion Trial
  59. HAT 1Heparin-Associated Thrombocytopenia 1
  60. HAT 2Heparin-Associated Thrombocytopenia 2
  61. COASTHeparin-Coated Stents In Small Coronary Arteries
  62. HAESTHeparin In Acute Embolic Stroke Trial
  63. HIPSHeparin Infusion Prior To Stenting
  64. HALT-CHepatitis C Antiviral Long-Term Treatment To Prevent Cirrhosis
  65. Hermann HelmholtzHermann von Helmholtz
  66. HerophilusHerophilos
  67. HeterosexualHeterosexuality
  68. High fructose corn syrupHigh-fructose corn syrup
  69. High altitude sicknessHigh altitude pulmonary edema
  70. High altitude exposureHigh altitude pulmonary edema
  71. HIT-IIIHirudin For Improvement Of Thrombolysis
  72. HIT-IHirudin For The Improvement Of Thrombolysis
  73. HERO-2Hirulog And Early Reperfusion Or Occlusion Trial
  74. Iodized saltHistory of iodised salt
  75. Iodised saltHistory of iodised salt
  76. HATHome Automatic External Defibrillator Trial
  77. HESTIAHome Evaluation Of Stroke Induced Aid
  78. HHHHome Or Hospital Heart Failure
  79. Homosexual menHomosexuality
  80. HomosexualHomosexuality
  81. Howard Ahmanson, JrHoward Ahmanson, Jr.
  82. Howard Walter FloreyHoward Florey, Baron Florey
  83. Howard T. RickettsHoward Taylor Ricketts
  84. Human Development IndexHttp://en.wikipedia.org/wiki/Human Development Index
  85. HALT-MIHu23F2G Anti-Adhesion To Limit Cytotoxic Injury Following Ami
  86. LuschkaHubert von Luschka
  87. Female sexualityHuman female sexuality
  88. Human Genetic EngineeringHuman genetic engineering
  89. Human herpesvirus 6Human herpes virus six
  90. Human sexual behaviourHuman sexual behavior
  91. Sexual activitiesHuman sexual behavior
  92. Sexual practiceHuman sexual behavior
  93. Sexual actHuman sexual behavior
  94. SexualHuman sexuality
  95. Sexual pleasureHuman sexuality#Sexual pleasure
  96. Lateral circumflex humeral arteryHumeral circumflex artery
  97. Sir Humphry DavyHumphry Davy
  98. Michael Ryan (mass murderer)Hungerford massacre
  99. Hurthle cell (patient information)Hurthle cell carcinoma (patient information)
  100. Communicating hydrocephalusHydrocephalus classification scheme
  101. HyperadrenocorticalismHyperadrenalcorticolism
  102. Ddx:HypergonadismHypergonadism
  103. HOSHypertension-Obesity-Sibutramine
  104. HDFPHypertension Detection And Follow-Up Program
  105. HEAT 2Hypertension Endothelin Antagonist Treatment
  106. Hypnogogic hallucinationsHypnogogia
  107. Low complement concentrationHypocomplimentemia
  108. Hypolipidemia classificationHypolipoproteinemia classification
  109. Hypolipidemia definitionHypolipoproteinemia definition
  110. Hypolipidemia differential diagnosisHypolipoproteinemia differential diagnosis
  111. Hypolipidemia epidemiology and demographicsHypolipoproteinemia epidemiology and demographics
  112. Hypolipidemia historical perspectiveHypolipoproteinemia historical perspective
  113. Hypolipidemia history and symptomsHypolipoproteinemia history and symptoms
  114. Hypolipidemia laboratory findingsHypolipoproteinemia laboratory findings
  115. Hypolipidemia medical therapyHypolipoproteinemia medical therapy
  116. Hypolipidemia natural history, complications and prognosisHypolipoproteinemia natural history, complications and prognosis
  117. Hypolipidemia overviewHypolipoproteinemia overview
  118. Hypolipidemia risk factorsHypolipoproteinemia risk factors
  119. C00-D48ICD 10 Chapter II
  120. D50-D89ICD 10 Chapter III
  121. E00-E90ICD 10 Chapter IV
  122. Ibn NafisIbn al-Nafis
  123. Soy ice creamIce cream
  124. IchthyophthiriusIchthyophthirius multifiliis
  125. IliumIlion (disambiguation)
  126. Elie MetchnikoffIlya Ilyich Mechnikov
  127. APOCARDImaging In Cardiac Transplant Patients
  128. STENTIM-2Immediate Coronary Angioplasty With Elective Wiktor Stent Implantation Compared With Conventional Balloon Angioplasty In Acute Myocardial Infarction
  129. ABOARDImmediate Versus Next Day Catheterization In Non-St Elevation Acute Coronary Syndrome
  130. CREATE-ECLA - GIKImpact Of Glucose-Insulin-Potassium On Mortality And Morbidity In Over 20,000 Patients With Acute Myocardial Infarction: The Create-Ecla International Trial
  131. RESISTImpact Of Intravascular Ultrasound Guidance In Stent Deployment On 6-Month Restenosis Rate: A Multicenter, Randomized Study Comparing Two Strategies--With And Without Intravascular Ultrasound Guidance
  132. ISAR-SHOCKImpella Lp2.5 Vs. Iabp In Cardiogenic Shock
  133. Imperial College of Science, Technology and MedicineImperial College London
  134. ICD9Implantable cardioverter difibrillator
  135. ICD10Implantable cardioverter difibrillator
  136. ICD-9Implantable cardioverter difibrillator
  137. International Classification of DiseasesImplantable cardioverter difibrillator
  138. IMPROVE-CHFImproved Management Of Patients With Congestive Heart Failure
  139. REGICORImprovement In Survival After Myocardial Infarction Between 1978-85 And 1986-88 In The Regicor Study
  140. TAXUS IIIIn-Stent Restenosis Treated With Stent-Based Delivery Of Paclitaxel Incorporated In A Slow-Release Polymer Formulation
  141. INTERCEPTIncomplete Infarction Trial Of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (Diltiazem)
  142. ANDROMEDAIncreased Mortality After Dronedarone Therapy For Severe Heart Failure
  143. INCOMINIndependent Comparison Of Interferon (Betaseron V. Avonex In Relapsing-Remitting Multiple Sclerosis (Rrms)
  144. Influenza (Flu) (For Patients)Influenza Patient Information
  145. Influenza (for patients)Influenza Patient Information
  146. FLUCADInfluenza Vaccination In Secondary Prevention From Coronary Ischemic Events In Coronary Artery Disease
  147. Flu researchInfluenza research
  148. Infrared lightInfrared
  149. Near infraredInfrared
  150. Infra-red radiationInfrared
  151. GUARDIANInhibition Of The Sodium-Hydrogen Exchanger With Cariporide To Prevent Myocardial Infarction In High-Risk Ischemic Situations: Main Results Of The Guard During Ischemia Against Necrosis (Guardian) Trial
  152. INTRINSIC RVInhibition Of Unnecessary Rv Pacing With Av Search Hysteresis In Icds
  153. IMPACT-HFInitiation Management Predischarge: Process For Assessment Of Carvedilol Therapy In Heart Failure
  154. Inner productInner product space
  155. Mosquito repellentInsect repellent
  156. InstarsInstar
  157. Woodbridge HospitalInstitute of Mental Health
  158. IRASInsulin Resistance Atherosclerosis Study
  159. Insulin Lispro Injection (patient information)Insulin lispro injection (patient information)
  160. Insulin Lispro InjectionInsulin lispro injection (patient information)
  161. IBIS-2Integrated Biomarker And Imaging Study-2
  162. INTERACTIntegrilin And Enoxaparin Randomized Assessment Of Acute Coronary Syndrome Treatment
  163. INTRO-AMIIntegrilin And Reduced Dose Of Thrombolytic In Acute Myocardial Infarction
  164. INTAMIIntegrilin In Acute Myocardial Infarction
  165. IMPACTIntegrilin To Manage Platelet Aggregation To Prevent Coronary Thrombosis International Mexiletine Or Placebo Antiarrhythmic Coronary TrialInternational Multiple Sclerosis Secondary Progressive Avonex Controlled Trial
  166. IMPACT IIIntegrilin To Minimise Platelet Aggregation And Coronary Thrombus - II
  167. Intelligence (trait)Intelligence
  168. Intelligence testIntelligence quotient
  169. I.Q.Intelligence quotient
  170. IVATIntermediate Sized Vessel Atherectomy Trial
  171. ICSSInternational Carotid Stenting Study (Cavatas-2)
  172. INJECTInternational Joint Efficacy Comparison Of Thrombolytics
  173. Red CrossInternational Red Cross and Red Crescent Movement
  174. ISAACInternational Study Of Asthma And Allergies In Childhood
  175. ISIS-2International Study Of Infarct Survival-2
  176. ISIS-3International Study Of Infarct Survival-3
  177. ISTICHInternational Surgical Trial In Intracerebral Hemorrhage
  178. International Symbol of AccessibilityInternational Symbol of Access
  179. IUPHARInternational Union of Basic and Clinical Pharmacology
  180. IUPACInternational Union of Pure and Applied Chemistry
  181. INVESTInternational Verapamil-Trandolapril Study
  182. IMSInterventional Management Of Stroke Study
  183. GENEVAIntracoronary Beta Irradiation To Reduce Restenosis After Balloon Angioplasty
  184. ISAR-PEACEIntracoronary Stenting And Angiographic Restenosis: Promote Endothelial Cells With Estradiol
  185. ISAR-TEST-3Intracoronary Stenting And Angiographic Restenosis Investigators – Test Efficacy Of Rapamycin-Eluting Stents With Different Polymer Coating Strategies
  186. ISAR-LEFT MAINIntracoronary Stenting And Angiographic Results: Drug-Eluting Stents For Unprotected Coronary Left Main Lesions
  187. ISAR-STEREO - 2Intracoronary Stenting And Angiographic Results - Strut Thicness Effect On Restenosis Outcome Trial - 2
  188. ISAR-TEST-2Intracoronary Stenting And Angiographic Results–Test Efficacy Of 3 Limus-Eluting Stents
  189. ISAR-CHOICEIntracoronary Stenting And Antithrombotic Regimen: Choose Between 3 High Oral Doses For Immediate Clopidogrel Effect
  190. ISAR-REACT 2Intracoronary Stenting And Antithrombotic Regimen: Rapid Early Action For Coronary Treatment
  191. ISAR REACTIntracoronary Stenting And Antithrombotic Regimen Rapid Early Action For Coronary Treatment
  192. ISAR-COOLIntracoronary Stenting With Antithrombotic Regimen Cooling-Off
  193. IHASTIntraoperative Hypothermia For Aneurysm Surgery Trial
  194. ICE-ITIntravascular Cooling Adjunctive To Primary Coronary Intervention
  195. IMAGESIntravenous Magnesium Efficacy In Stroke
  196. InTime-2Intravenous Npa For Treatment Of Infarcting Myocardium Early
  197. InTIMEIntravenous Npa For Treatment Of Infarcting Myocardium Early
  198. ISAMIntravenous Streptokinase In Acute Myocardial Infarction
  199. ICTUSInvasive Versus Conservative Treatment In Unstable Coronary Syndromes
  200. InvertInverse
  201. InvertebratesInvertebrate
  202. Invert sugarInverted sugar syrup
  203. ITALICSInvestigation By The Thoraxcenter On Antisense Dna Using Local Delivery And Ivus After Coronary Stenting
  204. InDDExInvestigation Into Delay To Diagnosis Of Alzheimer Disease With Exelon
  205. ILLUMINATEInvestigation Of Lipid Level Management To Understand Its Impact In Atherosclerotic Events
  206. ILLUSTRATEInvestigation Of Lipid Level Management Using Coronary Ultrasound To Assess Reduction Of Atherosclerosis By Cetp Inhibition And Hdl Elevation
  207. INTrEPIDInvestigation Of Non–Transplant-Eligible Patients Who Are Inotrope Dependent See
  208. FRESCOInvestigators In The Florence Randomized Elective Stenting In Acute Coronary Occlusions
  209. ICONIonic Versus Nonionic Contrast To Obviate Worsening Nephropathy After Angioplasty In Chronic Renal Failure Patients
  210. INTACTIressa Non–Small Cell Lung Cancer Trial Assessing Combination Treatment
  211. CamptosarIrinotecan hydrochloride
  212. Novaplus Irinotecan HydrochlorideIrinotecan hydrochloride
  213. NovaplusIrinotecan hydrochloride
  214. ISAR-SWEETIs Abciximab A Superior Way To Eliminate Elevated Thrombotic Risk In Diabetics
  215. IONDTIschemic Optic Neuropathy Decompression Trial
  216. Strontium-89Isotopes of strontium
  217. IN-CHFItalian Network - Congestive Heart Failure
  218. Ivan Petrovich PavlovIvan Pavlov
  219. Contextual therapyIván Böszörményi-Nagy
  220. J.J. ThomsonJ. J. Thomson
  221. Jack Cecil DrummondJack Drummond
  222. Jakob BernoulliJacob Bernoulli
  223. James BlundellJames Blundell (physician)
  224. James WatsonJames D. Watson
  225. James Dewey WatsonJames D. Watson
  226. James Simpson (doctor)James Young Simpson
  227. Jan Evangelista PurkinjeJan Evangelista Purkyně
  228. JELISJapan Epa Lipid Intervention Study
  229. J-WINDJapan Working Groups Of Acute Myocardial Infarction For The Reduction Of Necrotic Damage By Atrial Natriuretic Peptide Or Nicorandil
  230. JPADJapanese Primary Prevention Of Atherosclerosis With Aspirin For Diabetes
  231. JSAPJapanese Stable Angina Pectoris Study
  232. Jarrow-Turnbull modelJarrow–Turnbull model
  233. Jean-Baptiste de LamarckJean-Baptiste Lamarck
  234. Jean Baptiste LamarckJean-Baptiste Lamarck
  235. Talairach coordinatesJean Talairach
  236. Joseph LoschmidtJohann Josef Loschmidt
  237. Johann HittorfJohann Wilhelm Hittorf
  238. John PolanyiJohn Charles Polanyi
  239. Sir John RandallJohn Randall (physicist)
  240. JUMBO-TIMI 26Joint Utilisation Of Medications To Block Platelets Optimally
  241. Salk vaccineJonas Salk
  242. J.W. GibbsJosiah Willard Gibbs
  243. Julius CohnheimJulius Friedrich Cohnheim
  244. Jons Jakob BerzeliusJöns Jakob Berzelius
  245. Kaj Ulrik Linderstrom-LangKaj Ulrik Linderstrøm-Lang
  246. Karolinska InstituteKarolinska Institutet
  247. P-32Kel-Tec P-32
  248. Shibasaburo KitasatoKitasato Shibasaburo
  249. KosherKosher foods
  250. KAT IIKuopio Angiogenesis Trial
  251. AzureLapis lazuli
  252. Laplace’s LawLaplace’s law
  253. LACILaser Angioplasty For Critical Ischemia
  254. LATELate Assessment Of Thrombolytic Efficacy Study
  255. BASKET LATELate Clinical Events Related To Late Stent Thrombosis After Stopping Clopidogrel
  256. LASMALate aquired stent malapposition
  257. Lateral cutaneous branches of torsoLateral abdominal cutaneous branch of intercostal nerve
  258. Leopold RuzickaLavoslav Ružička
  259. Lazar EdeleanuLazăr Edeleanu
  260. GuardianshipLegal guardian
  261. Guardian ad litemLegal guardian
  262. Lehmann-Scheffé theoremLehmann–Scheffé theorem
  263. Lemon oilLemon
  264. Lemon BalmLemon balm
  265. LISALescol In Severe Atherosclerosis Trial
  266. LIPSLescol Intervention Prevention Study
  267. LIDOLevosimendan Infusion Versus Dobutamine
  268. Jaffe-Lichtenstein-Sutro syndromeLichtenstein syndrome
  269. LHTLifestyle Heart Trial
  270. Light-chain nephropathyLight chain disease
  271. Light sourceLight sources
  272. LIMBLimbs International Medical Buflomedil Trial
  273. LIMIT AMILimitation Of Myocardial Infarction Following Thrombolysis In Acute
  274. LEADERSLimus Eluted From A Durable Vs Erodable Stent Coating
  275. LipsLip (disambiguation)
  276. L-CADLipid-Coronary Artery Disease (Pravastatin)
  277. SLIPLipid Profile During Antihypertensive Treatment
  278. LRC-CPPTLipid Research Clinics Coronary Primary Prevention Trial
  279. Ddx:Lipoprotein (a)Lipoprotein (a)
  280. Hyperlipidemia case study oneLipoprotein disorders case study one
  281. Hyperlipidemia cost-effectiveness of therapyLipoprotein disorders cost-effectiveness of therapy
  282. Hyperlipidemia differential diagnosisLipoprotein disorders differential diagnosis
  283. Hyperlipidemia epidemiology and demographicsLipoprotein disorders epidemiology and demographics
  284. Hyperlipidemia future or investigational therapiesLipoprotein disorders future or investigational therapies
  285. Hyperlipidemia history and symptomsLipoprotein disorders history and symptoms
  286. Hyperlipidemia laboratory findingsLipoprotein disorders laboratory findings
  287. Hyperlipidemia medical therapyLipoprotein disorders medical therapy
  288. Hyperlipidemia natural history, complications and prognosisLipoprotein disorders natural history, complications and prognosis
  289. Hyperlipidemia pathophysiologyLipoprotein disorders pathophysiology
  290. Genetics of lipoprotein disordersLipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  291. Genetics of primary lipoprotein disordersLipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  292. Lipoprotein disorders geneticsLipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  293. Dyslipidemia geneticsLipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  294. Genes in hyperlipidemiaLipoprotein disorders pathophysiology#Genetics of Primary Lipoprotein Disorders
  295. Hyperlipidemia physical examinationLipoprotein disorders physical examination
  296. Hyperlipidemia risk factorsLipoprotein disorders risk factors
  297. Hyperlipidemia screeningLipoprotein disorders screening
  298. Lippincott Williams and WilkinsLippincott Williams & Wilkins
  299. Lisinopril PregnancyLisinopril pregnancy
  300. List of notable people diagnosed with Crohn's diseaseList of people diagnosed with Crohn's disease
  301. Chemistry journalList of scientific journals in chemistry
  302. Statistical packageList of statistical packages
  303. Atrophie BlancheLivedoid Vasculitis
  304. WikiDoc state of the art review on Lo OvralLo Ovral detailed information
  305. Gamma-OneLocalized Intracoronary Gamma-Radiation Therapy To Inhibit The Recurrence Of Restenosis After Stenting
  306. LAMPLocally Advanced Multimodality Protoco
  307. Lognormal distributionLog-normal distribution
  308. LognormalLog-normal distribution
  309. LADIPLoire-Ardèche-Drôme-Isère-Puy-De-Dôme
  310. ENCORE IILong-Term Effect Of Nifedipine On Vasomotion And Vessel Morphology In Patients With Coronary Artery Disease: An Intravascular Ultrasound-Assisted Evaluation
  311. SCATLong-Term Effects Of Cholesterol Lowering And Angiotension-Converting Enzyme Inhibition On Coronary Atherosclerosis. The Simvastatin/Enalapril Coronary Atherosclerosis Trial (Scat).
  312. LIPIDLong-Term Intervention With Pravastatin In Ischemic Disease Trial
  313. SPICLong-Term Survival Effect Of Metoprolol In Dilated Cardiomyopathy
  314. Long haul COVIDLong COVID syndrome
  315. ELITE-IILosartan Heart Failure Survival Study
  316. LIFELosartan Intervention For Endpoint Reduction In Hypertension (Life) Study
  317. Louis J. IgnarroLouis Ignarro
  318. PasteurLouis Pasteur
  319. Love biteLove-bite
  320. REDUCELow Molecular Weight Heparin (Reviparin) In Percutaneous Transluminal Coronary Angioplasty
  321. CREATE ELCA - ReviparinLow Molecular Weight Heparin (Reviparin) In Preventing Mortality, Reinfarction, And Strokes In Over 15,500 Patients With St Elevation Acute Myocardial Infarction
  322. LEADERLower Extremity Arterial Disease Event Reduction Trial
  323. E. von DungernLudwik Hirszfeld
  324. Luis LeloirLuis Federico Leloir
  325. LofflerLöffler's syndrome
  326. Loffler syndromeLöffler's syndrome
  327. Lofflers syndromeLöffler's syndrome
  328. LofflersLöffler's syndrome
  329. Loffler's syndromeLöffler's syndrome
  330. Loffler'sLöffler's syndrome
  331. EURIDIS and ADONISMaintenance Of Sinus Rhythm With Dronedarone In Patients With Atrial Fibrillation Or Flutter
  332. Male HealthMale Health Professionals Study
  333. Mallory-Weiss syndrome endoscopyMallory-Weiss syndrome other imaging studies
  334. MammalsMammal
  335. MammalianMammal
  336. MATCHManagement Of Atherothrombosis With Clopidogrel In High-Risk Patients
  337. MASCOTManagement Of Atrial Fibrillation Suppression In Af-Hf Comorbidity Therapy
  338. MEGAManagement Of Elevated Cholesterol In The Primary Prevention Group Of Adult Japanese
  339. MAPPET-3Management Strategies And Prognosis Of Pulmonary Embolism-3 Trial
  340. Speech productionManner of articulation
  341. Marek diseaseMarek's disease
  342. Avian lymphomatosis virusMarek's disease
  343. Markov Chain Monte CarloMarkov chain Monte Carlo
  344. Marshall NirenbergMarshall Warren Nirenberg
  345. Marshall W. NirenbergMarshall Warren Nirenberg
  346. Typhoid MaryMary Mallon
  347. MasculineMasculinity
  348. CopulateMating
  349. Gerson therapyMax Gerson
  350. Max Planck InstituteMax Planck Society
  351. Max Johann Sigismund SchultzeMax Schultze
  352. MITRAMaximal Individual Therapy In Acute Myocardial Infarction
  353. MEND-CABG IIMc-1 To Eliminate Necrosis And Damage In Coronary Artery Bypass Graft Surgery II — Presented At Scai-Acc I2 Summit/Acc 2008
  354. METEORMeasuring Effects On Intima-Media Thickness: An Evaluation Of Rosuvastatin
  355. MediallyMedial (disambiguation)
  356. Mediastinal granulomaMediastinal fibrosis
  357. MCATMedical College Admission Test
  358. CAPE IIMedical Treatment Of Myocardial Ischemia In Coronary Artery Disease: Effect Of Drug Regime And Irregular Dosing In The Cape II Trial
  359. Algorithm (medical)Medical algorithm
  360. MATEMedicine Versus Angiography In Thrombolytic Exclusion Trial
  361. Medicines and Healthcare Products Regulatory AgencyMedicines and Healthcare products Regulatory Agency
  362. MHRAMedicines and Healthcare products Regulatory Agency
  363. Medullary carcinomaMedullary Carcinoma
  364. Sloan-Kettering Institute for Cancer ResearchMemorial Sloan-Kettering Cancer Center
  365. Merck & Co., Inc.Merck & Co.
  366. Merck & CoMerck & Co.
  367. Merck ManualMerck Manual of Diagnosis and Therapy
  368. MERLIN-TIMI 36Metabolic Efficiency With Ranolazine For Less Ischemia In Nste-Acs
  369. Metabolic syndrome natural history , complications & prognosisMetabolic syndrome natural history, complications & prognosis
  370. PamineMethscopolamine
  371. Pamine ForteMethscopolamine
  372. MaVSMetoprolol After Vascular Surgery
  373. MERIT-HFMetoprolol Cr/Xl Randomized Intervention Trial In Congestive Heart Failure
  374. MIAMIMetoprolol In Acute Myocardial Infarction
  375. MDCMetoprolol In Dilated Cardiomyopathy Trial
  376. Metre per second squaredMetre per square second
  377. Meter per second squaredMetre per square second
  378. Michel ChevreulMichel Eugène Chevreul
  379. MICRO-HOPEMicroalbuminuria, Cardiovascular, And Renal Outcomes - Heart Outcomes Prevention Evaluation
  380. How to creat an expanded navigation boxMicrochapter template
  381. How to create an expanded navigation boxMicrochapter template
  382. Microvolt T Wave Alternans Test (MTWA): News from AHA 2007Microvolt T Wave Alternans Test (MTWA) not Predictive of Life-Threatening Arrhythmias
  383. MASTERMicrovolt T Wave Alternans Testing For Risk Stratification Of Post-Myocardial Infarction Patients
  384. MidrangeMid-range
  385. MERLINMiddlesbrough Early Revascularization To Limit Infarction
  386. MISTMigraine Intervention With Starflex Technology
  387. MinorityMinority group
  388. Mitral Regurgitation general approach to mitral regurgitationMitral Regurgitation intern survival guide
  389. Complications and Prognosis of MSMitral stenosis complications and prognosis
  390. Mitral stenosis VideosMitral stenosis videos
  391. Mixed mullerian tumor case study oneMixed Mullerian tumor case study one
  392. Mixed mullerian tumor stagingMixed Mullerian tumor staging
  393. MOSTMode Selection Trial (Most) In Sinus Node Dysfunction
  394. MDRDModification Of Diet In Renal Disease Study
  395. Moexipril tabletMoexipril Hydrochloride
  396. Watson and CrickMolecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid
  397. MolluskMollusca
  398. MolluscMollusca
  399. MONICAMonitoring Trends And Determinants In Cardiovascular Disease
  400. MonoclonalMonoclonal Antibodies
  401. MonotremesMonotreme
  402. M-HARTMontreal Heart Attack Readjustment Trial
  403. BEAUTIFULMorbidity-Mortality Evaluation Of The If Inhibitor Ivabradine In Patients With Coronary Disease And Left-Ventricular Dysfunction
  404. GEMICAMorbidity And Mortality Following Early Administration Of Amiodarone In Myocardial Infarction
  405. MACH-1Mortality Assessment In Congestive Heart Failure Trial
  406. MaternalMother
  407. MADIT-IIMulticenter Automatic Defibrillator Implantation Trial II
  408. MUST-EECPMulticenter Enhanced External Counterpulsation
  409. ENDEAVOR-1Multicenter Evaluation Of Abt-578 Elution From A Phosphorylcholine-Coated Stent
  410. FUTURE IIMulticenter Evaluation Of The Biosbsorbable Polymer-Based Everolimus-Eluting Stent
  411. MIRACLE ICDMulticenter Insync Implantable Cardioversion Defibrillation Randomized Clinical Evaluation
  412. M-PATHYMulticenter Pacing Therapy
  413. TEAM-2Multicenter Patency Trial Of Intravenous Antistreplase Compared With Streptokinase In Acute Myocardial Infarction
  414. MPIPMulticenter Post-Infarction Program
  415. LONG-DESMulticenter Prospective Nonrandomized Registry Study For Drug-Eluting Stents In Very Long Coronary Lesions (Cypher Vs Taxus)
  416. MR PCIMulticenter Registry Of High-Risk Percutaneous Coronary Intervention And Adequate Platelet Inhibition
  417. MOMENTUMMulticenter Trial Of The Orqis Medical Cancion System For The Enhanced Treatment Of Heart Failure Unresponsive To Medical Therapy
  418. MUSICMulticenter Ultrasound Guided Stent Implantation In The Coronaries
  419. MUSTTMulticenter Unsustained Tachycardia Trial
  420. MEDAL ProgramMultinational Etoricoxib And Diclofenac Arthritis Long-Term Study Program
  421. MILISMultiple Center Investigation Of The Limit Of Infarction
  422. MRFITMultiple Risk Factor Intervention Trial
  423. INSYNCMultisite Pacing As A Supplemental Treatment Of Congestive Heart Failure: The Medtronic Inc. Insync Study
  424. MUSTICMultisite Stimulation In Cardiomyopathies Study
  425. MultituberculatesMultituberculata
  426. MHFTMunich Mild Heart Failure Trial
  427. MD CARE ActMuscular Dystrophy Community Assistance Research and Education Amendments of 2001
  428. Muscular Dystrophy Coordinating CommitteeMuscular Dystrophy Community Assistance Research and Education Amendments of 2001#MDCC
  429. Myelodysplastic-myeloproliferative diseasesMyelodysplastic myeloproliferative diseases
  430. MAGIC – Presented at AHA 2006Myoblast Autologous Grafting In Ischemic Cardiomyopathy
  431. MITI IIMyocardial Infarction Triage And Intervention Project--Phase I
  432. MITI IMyocardial Infarction Triage And Intervention Project--Phase I
  433. REGENTMyocardial Regeneration By Intracoronary Infusion Of Selected Population Of Stem Cells In Acute Myocardial Infarction
  434. Coronary angiography myocardial bridgeMyocardial bridge#Coronary Angiography
  435. PCI myocardial bridgeMyocardial bridge#Treatment#PCI/Stenting
  436. PCI myocardial bridgingMyocardial bridge#Treatment#PCI/Stenting
  437. DCCN,N'-Dicyclohexylcarbodiimide
  438. 1-ButanolN-Butanol
  439. EXPEDITIONNa+/H+ Exchange Inhibition To Prevent Coronary Events In Acute Cardiac Conditions
  440. Nagayoshi NagaiNagai Nagayoshi
  441. Common nomenclatureNaming convention
  442. NIOSHNational Institute for Occupational Safety and Health
  443. NICHDNational Institute of Child Health and Human Development
  444. NICS-EHNational Intervention Cooperative Study In Elderly Hypertensives
  445. NRMI-2National Registry Of Myocardial Infarction (Second Phase)
  446. ThanatophobiaNecrophobia
  447. NEPHRICNephrotoxicity In High-Risk Patients Study Of Isoosmolar And Low-Osmolar Non-Ionic Contrast Media Study
  448. NAPANesiritide Administered Peri-Anesthesia In Patients Undergoing Cardiac Surgery
  449. New International EncyclopediaNew international encyclopedia
  450. NHLBI DynamicNhlbi Dynamic Registry Of Percutaneous Interventions: A Comparison To The 1985-86 Registry
  451. WikiDoc state of the art review on NicotineNicotine detailed information
  452. NAMISNifedipine Angina Myocardial Infarction Study
  453. Nikolai KorotkoffNikolai Korotkov
  454. Nikolay Nikolaevich ZininNikolay Zinin
  455. NICOLENisoldipine For Coronary Artery Disease In Leuven
  456. NO-PAINNitric Oxide In Peripheral Arterial Insufficiency
  457. Mutual masturbationNon-penetrative sex#Mutual masturbation
  458. Unstable Angina / Non ST Elevation Myocardial Infarction: Natural HistoryNon ST Elevation Myocardial Infarction: Natural History
  459. Non small cell carcinoma of the lung (patient information)Non Small Cell Carcinoma of the Lung (patient information)
  460. Non-small cell lung carcinoma stagingNon small cell lung cancer staging
  461. NORDILNordic Diltiazem Study
  462. NormalNormality (behavior)
  463. NICE-SUGARNormoglycemia In Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation
  464. NASCETNorth American Symptomatic Carotid Endarterectomy Trial
  465. Norwegian NifedipineNorwegian Nifedipine Multi-Center Trial
  466. NORVITNorwegian Vitamin Trial
  467. GeigyNovartis
  468. Novartis Vaccines and DiagnosticsNovartis
  469. Novartis AGNovartis
  470. NAPLES IINovel Approaches For Preventing Or Limiting Events II
  471. FissionNuclear fission
  472. NUMBNumb
  473. Numerical instabilityNumerical stability
  474. EUROACTIONNurse-Coordinated Multidisciplinary, Family-Based Cardiovascular Disease Prevention Programme
  475. NutritionistsNutritionist
  476. OASIS-6 – GIKOasis-6 – Glucose-Insulin-Potassium
  477. OATOccluded Artery Trial
  478. ESPRIT HRTOestrogen In The Prevention Of Reinfarction Trial
  479. OVERTUREOmapatrilat Versus Enalapril Randomized Trial Of Utility In Reducing Events
  480. OCLAOmeprazole Clopidogrel Aspirin
  481. OmmatidiaOmmatidium
  482. The Origin of SpeciesOn the Origin of Species
  483. Oxyphilic adenomaOncocytoma
  484. ONTARGETOngoing Telmisartan Alone And In Combination With Ramipril Global Endpoint Trial
  485. On-TIME 2Ongoing Tirofiban In Myocardial Infarction Evaluation 2 Trial
  486. ON-TIMEOngoing Tirofiban In Myocardial Infarction Evaluation Trial
  487. OPALSOntario Prehospital Advanced Life Support
  488. InoperableOperability
  489. Early spider orchidOphrys sphegodes
  490. DidelphimorphiaOpossum
  491. ODESSAOptical Coherence Tomography For Des Safety
  492. Fiber opticsOptical fiber
  493. Fiber opticOptical fiber
  494. OPUSOptimal Angioplasty Versus Primary Stenting
  495. OARSOptimal Atherectomy Restenosis Study
  496. OCBASOptimal Coronary Balloon Angioplasty With Provisional Stenting Vs. Stent Trial
  497. Editing Optimal Medical Therapy or PCI: Occluded Artery Trial (OAT) Reveals the More Cost-Effective TreatmentOptimal Medical Therapy or PCI: Occluded Artery Trial (OAT) Reveals the More Cost-Effective Treatment
  498. OPTICOptimal Pharmacological Therapy In Cardioverter Defibrillator Patients Trial
  499. ODIXa-HIPOral, Direct Factor Xa Inhibitor, Bay 59-7939, Given Once Daily In Patients Undergoing Total Hip Replacement
  500. Oral Thrush (patient information)Oral Candidiasis (patient information)

View ( | ) (20 | 50 | 100 | 250 | 500)